US Dollar vs MXN

Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

Regístrate

CNTA Centessa Pharmaceuticals PLC

9.53

0.00 (0.00%)

Pre Mercado

Última actualización: 03:17:03

Retrasado por 15 minutos

Form ARS - Annual Report to Security Holders

Centessa Pharmaceuticals (NASDAQ:CNTA)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Haga Click aquí para más Gráficas Centessa Pharmaceuticals.

Centessa Pharmaceuticals (NASDAQ:CNTA)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024

Haga Click aquí para más Gráficas Centessa Pharmaceuticals.

Noticias sobre Centessa Pharmaceuticals PLC CNTA

Form 8-K - Current report
Lunes 10 de Junio 2024 (1 semana hace) • Edgar (US Regulatory)

Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer
Lunes 10 de Junio 2024 (1 semana hace) • GlobeNewswire Inc.

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
Martes 21 de Mayo 2024 (4 semanas hace) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Lunes 13 de Mayo 2024 (1 mes hace) • Edgar (US Regulatory)

Form 8-K - Current report
Lunes 13 de Mayo 2024 (1 mes hace) • Edgar (US Regulatory)

Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024
Lunes 13 de Mayo 2024 (1 mes hace) • GlobeNewswire Inc.

Form ARS - Annual Report to Security Holders
Jueves 9 de Mayo 2024 (1 mes hace) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Jueves 9 de Mayo 2024 (1 mes hace) • Edgar (US Regulatory)

Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares
Martes 23 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Martes 23 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Centessa Pharmaceuticals Announces Open IND for ORX750; Proof-of-Concept Data in Sleep-Deprived Healthy Volunteers Planned for 2H 2024
Lunes 22 de Abril 2024 (2 meses hace) • GlobeNewswire Inc.

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
Jueves 28 de Marzo 2024 (3 meses hace) • GlobeNewswire Inc.

Más de Centessa Pharmaceuticals PLC Artículos de Noticias

OMX Stockholm Travel and...

Mediobanca Banca di Cred...

Japan Exchange (PK)

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones